CAR T-cell-associated neurotoxicity: A comprehensive review.

Chimeric antigen receptor T-cell (CAR T-cell) therapies have emerged as a promising treatment modality for several malignancies, particularly haematological malignancies, by inducing robust antitumour responses. However, CAR T-cell therapies are associated with a spectrum of adverse events, including neurological complications. We here provide a review of neurological adverse events observed in patients undergoing CAR T-cell therapy, focusing on their incidence, clinical manifestations, underlying mechanisms and potential management strategies.

An evolutionary view of the function of CC-type glutaredoxins in plant development and adaptation to the environment.

Land plants have to face an oxidizing, heterogeneous, and fast changing environment. Redox-dependent post-translational modifications emerge as a critical component of plant responses to stresses. Among the thiol oxidoreductase superfamily, class III CC-type glutaredoxins (called ROXYs) are land plant specific, and their evolutionary history is highly dynamic.

[Better assessment, better care: Quetci, a questionnaire for assessing cognitive disorders in nursing practice].

Cognitive disorders can have significant repercussions on the quality of care and daily life for patients. We have developed a new tool specifically designed for nursing practice to identify these problems in patients with brain tumors. The Cognitive Impairment Assessment Questionnaire for nursing practice is an objective, quick and easy-to-administer tool that is readily accepted by patients.